Energy Balance During Ketosis in Rat Brain

大鼠大脑酮症期间的能量平衡

基本信息

  • 批准号:
    7812117
  • 负责人:
  • 金额:
    $ 19.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The uptake and metabolism of ketone bodies in brain have been of interest to researchers and clinicians for decades but how they affect the coupling of blood flow and glucose metabolism, especially during chronic ketotic conditions, remains unclear. Although glucose is considered the primary fuel for brain, ketones supplement brain metabolism, especially under conditions of glucose sparing, such as fasting, starvation or high fat-low carbohydrate diet. The enzymes for ketone metabolism and the monocarboxylate transporters at the blood brain barrier are known to increase with fasting or ketogenic diet. It is known that cerebral ischemia, such as stroke (induced by cardiac arrest and resuscitation), results in altered glucose metabolism, the reduction of intracellular energy metabolites such as ATP, ADP and phosphocreatine and the accumulation of metabolic intermediates, such as lactate and adenosine. Degree of recovery of neurologic function following stroke (oxidative stress) is limited by the ability of the central nervous system to recover from an ischemic event. Based on our experiences we have developed the working hypothesis that ketones are effective against pathology associated with oxidative stress and/or altered glucose metabolism. The rationale is ketosis stabilizes glucose metabolism through the normalization of redox (lactate/pyruvate ratio) in brain. One potential mechanism is that ketone body metabolism differs from glucose such that when oxidized, acetyl-CoA units enter the Krebs-TCA cycle at the level of citrate bypassing glycolysis (the step after pyruvate dehydrogenase complex which is often a metabolic block following oxidative stress) and through feed-back regulation is known to down regulate glycolytic rates at the level of citrate, phosphofructokinase or hexokinase. Another proposed mechanism may be that ketosis facilitates anaplerosis (replenishment of the Krebs-TCA cycle intermediates) after oxidative challenges, a mechanism for neuroprotection. To investigate the effects of ketosis on cerebral metabolic rate for glucose (CMRglu) imaging modalities, such as PET analysis, and an in vivo rat model of ketosis will be used to determine if ketosis improves CMRglu and metabolic outcome following cardiac arrest and resuscitation. PUBLIC HEALTH RELEVANCE: Fasting, prolonged starvation or consumption of high fat-low carbohydrate diet (ketogenic diet) is known to result in ketosis and has been used for the treatment of intractable epilepsy, especially where the seizures are caused by insufficient glucose transport into the brain. Based on animal studies, ketosis has been suggested to possess neuroprotective properties against neurodegenerative diseases such as Alzheimer's, Parkinson's and recovery from focal stroke. However, there has been little progress in developing therapies that optimize ketosis as an approach to the medical treatment of neurodegenerative diseases, and, therefore, we would like to investigate the effects of ketosis on brain metabolism of glucose (CMRglu) using image (PET) analysis in ketotic rat and to determine if there is improved outcome following cardiac arrest and resuscitation.
描述(由申请人提供):几十年来,研究人员和临床医生一直对大脑中酮体的摄取和代谢感兴趣,但它们如何影响血流和葡萄糖代谢的耦合,特别是在慢性酮症条件下,仍不清楚。虽然葡萄糖被认为是大脑的主要燃料,但酮可以补充大脑的新陈代谢,特别是在葡萄糖不足的情况下,例如禁食、饥饿或高脂肪低碳水化合物饮食。已知酮代谢酶和血脑屏障处的单羧酸转运蛋白会随着禁食或生酮饮食而增加。众所周知,脑缺血,如中风(由心脏骤停和复苏引起),会导致葡萄糖代谢改变,细胞内能量代谢物(如 ATP、ADP 和磷酸肌酸)减少,以及代谢中间体(如乳酸和腺苷)积累。中风(氧化应激)后神经功能的恢复程度受到中枢神经系统从缺血事件中恢复的能力的限制。根据我们的经验,我们提出了一个工作假设,即酮可以有效对抗与氧化应激和/或葡萄糖代谢改变相关的病理。其基本原理是酮症通过大脑中氧化还原(乳酸/丙酮酸比率)的正常化来稳定葡萄糖代谢。一种潜在的机制是酮体代谢与葡萄糖不同,因此当氧化时,乙酰辅酶A单位以柠檬酸水平进入克雷布斯-TCA循环,绕过糖酵解(丙酮酸脱氢酶复合物之后的步骤,通常是氧化应激后的代谢障碍)已知通过反馈调节可以下调柠檬酸、磷酸果糖激酶或己糖激酶水平的糖酵解速率。另一个提出的机制可能是酮症在氧化挑战后促进回补(Krebs-TCA 循环中间体的补充),这是一种神经保护机制。为了研究酮症对大脑葡萄糖代谢率 (CMRglu) 的影响,将使用 PET 分析等成像方式和体内酮症大鼠模型来确定酮症是否改善心脏骤停和复苏后的 CMRglu 和代谢结果。公共卫生相关性:已知禁食、长期饥饿或食用高脂低碳水化合物饮食(生酮饮食)会导致酮症,并已用于治疗顽固性癫痫,特别是由于葡萄糖转运至体内不足而引起癫痫发作的情况。脑。根据动物研究,酮症被认为具有神经保护特性,可预防阿尔茨海默病、帕金森病和局灶性中风等神经退行性疾病。然而,在开发优化酮症作为神经退行性疾病医学治疗方法的疗法方面进展甚微,因此,我们希望使用图像 (PET) 研究酮症对大脑葡萄糖代谢 (CMRglu) 的影响对酮症大鼠进行分析,以确定心脏骤停和复苏后的结果是否有所改善。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Charles Lamanna其他文献

Joseph Charles Lamanna的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Charles Lamanna', 18)}}的其他基金

Training in Neurodegenerative Diseases
神经退行性疾病培训
  • 批准号:
    8682902
  • 财政年份:
    2013
  • 资助金额:
    $ 19.43万
  • 项目类别:
Training in Neurodegenerative Diseases
神经退行性疾病培训
  • 批准号:
    8474459
  • 财政年份:
    2013
  • 资助金额:
    $ 19.43万
  • 项目类别:
Brain Energy Metabolism & Blood Flow 2010 Gordon Research Conference
脑能量代谢
  • 批准号:
    7993768
  • 财政年份:
    2010
  • 资助金额:
    $ 19.43万
  • 项目类别:
Angiogenic Response to Hypoxia and Ketosis in Rat Brain
大鼠脑中缺氧和酮症的血管生成反应
  • 批准号:
    7787036
  • 财政年份:
    2009
  • 资助金额:
    $ 19.43万
  • 项目类别:
Angiogenic Response to Hypoxia and Ketosis in Rat Brain
大鼠脑中缺氧和酮症的血管生成反应
  • 批准号:
    8038365
  • 财政年份:
    2009
  • 资助金额:
    $ 19.43万
  • 项目类别:
Angiogenic Response to Hypoxia and Ketosis in Rat Brain
大鼠脑中缺氧和酮症的血管生成反应
  • 批准号:
    8247822
  • 财政年份:
    2009
  • 资助金额:
    $ 19.43万
  • 项目类别:
Angiogenic Response to Hypoxia and Ketosis in Rat Brain
大鼠脑中缺氧和酮症的血管生成反应
  • 批准号:
    8247822
  • 财政年份:
    2009
  • 资助金额:
    $ 19.43万
  • 项目类别:
Angiogenic Response to Hypoxia and Ketosis in Rat Brain
大鼠脑中缺氧和酮症的血管生成反应
  • 批准号:
    8038365
  • 财政年份:
    2009
  • 资助金额:
    $ 19.43万
  • 项目类别:
Angiogenic Response to Hypoxia and Ketosis in Rat Brain
大鼠脑中缺氧和酮症的血管生成反应
  • 批准号:
    7787036
  • 财政年份:
    2009
  • 资助金额:
    $ 19.43万
  • 项目类别:
Angiogenic Response to Hypoxia and Ketosis in Rat Brain
大鼠脑中缺氧和酮症的血管生成反应
  • 批准号:
    7653555
  • 财政年份:
    2009
  • 资助金额:
    $ 19.43万
  • 项目类别:

相似国自然基金

乙酰辅酶A合成酶2(ACSS2)调控内侧前额叶皮层神经元的活性在抑郁发病中的作用及机制研究
  • 批准号:
    82301698
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
乙酰磷酸通过调节乙酰辅酶A的合成影响大肠杆菌甲氧苄啶耐药性的分子机制研究
  • 批准号:
    32370193
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
过氧化物酶体β-氧化通过乙酰辅酶A调控过氧化物酶体稳态的分子机制研究
  • 批准号:
    32370738
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
乙酰辅酶A合成酶点突变在青蒿素类药物抗性中的作用及机制研究
  • 批准号:
    32370543
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Epigenetic-metabolic aspects of alcohol use disorder and early developmental alcohol exposure
酒精使用障碍和早期发育酒精暴露的表观遗传代谢方面
  • 批准号:
    10745787
  • 财政年份:
    2023
  • 资助金额:
    $ 19.43万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 19.43万
  • 项目类别:
Spatial Acetyl-CoA metabolism as a regulator of Hallmarks of Aging
空间乙酰辅酶A代谢作为衰老标志的调节剂
  • 批准号:
    10901039
  • 财政年份:
    2023
  • 资助金额:
    $ 19.43万
  • 项目类别:
Elucidating the role of hepatic mTORC2 as a key regulator of carbohydrate metabolism in non-alcoholic fatty liver disease
阐明肝脏 mTORC2 作为碳水化合物代谢关键调节因子在非酒精性脂肪肝中的作用
  • 批准号:
    10387520
  • 财政年份:
    2022
  • 资助金额:
    $ 19.43万
  • 项目类别:
Elucidating the role of hepatic mTORC2 as a key regulator of carbohydrate metabolism in non-alcoholic fatty liver disease
阐明肝脏 mTORC2 作为碳水化合物代谢关键调节因子在非酒精性脂肪肝中的作用
  • 批准号:
    10548816
  • 财政年份:
    2022
  • 资助金额:
    $ 19.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了